Rück, Katharina
Preview |
PDF, English
Download (21MB) | Terms of use |
Citation of documents: Please do not cite the URL that is displayed in your browser location input, instead use the DOI, URN or the persistent URL below, as we can guarantee their long-time accessibility.
Abstract
Defeating cancer is one of the major challenges that humankind is facing today. To this end, nuclear medicine offers promising approaches including radiometal-based pharmaceuticals. The work presented in this thesis focused on the development of new ligand systems for application as metal-chelating units in radiopharmaceuticals. These novel ligands were evaluated in various non-radioactive and radioactive metal complexation studies concerning their potential application in nuclear medicine.
| Document type: | Dissertation |
|---|---|
| Supervisor: | Comba, Prof. Dr. Peter |
| Date of thesis defense: | 14 July 2017 |
| Date Deposited: | 17 Aug 2017 09:13 |
| Date: | 2017 |
| Faculties / Institutes: | Fakultät für Chemie und Geowissenschaften > Institute of Inorganic Chemistry |
| DDC-classification: | 500 Natural sciences and mathematics 540 Chemistry and allied sciences |
| Uncontrolled Keywords: | Ligand synthesis, Coordination chemistry, Nuclear medicine |
